FDA clears Masimo’s Rad-G pulse oximeter

Masimo (NSDQ:MASI) said today that FDA has granted a 510(k) clearance for its rugged handheld Rad-G pulse oximeter.
The Rad-G provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for both spot-checking and continuous monitoring, according to Masimo.
Other product descriptions and claims from Masimo include a long-lasting rechargeable battery, robust rubber casing, and a light weight. There’s also the new multipurpose, direct-connect Rad-G Sensor sensor for both adults and children.
The goal is to make it easier for clinicians to quickly assess patients and make informed care decisions anywhere pulse oximetry or vital signs checking is needed in a compact, portable form factor. It’s possible to use the Rad-G in a variety of settings: physicians’ offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, limited-resource environments and more.
“With the Rad-G Pulse Oximeter, we set out to create an accessible, high-quality care solution that clinicians can rely on in a multitude of care settings,” Masimo Joe Kiani said in a news release.
“We are bringing our expertise in pulse oximetry to a smaller, more lightweight, rugged, and versatile handheld device — without sacrificing any of the advantages that help provide clinicians with critical insights into patient status. As the COVID-19 pandemic continues, it’s more imperative than ever that caregivers have access to the most accurate and reliable pulse oximetry monitoring technologies.”
Original Article: (https://www.massdevice.com/fda-clears-masimos-rad-g-pulse-oximeter/)